Site icon AIT365

Sequoia Biotech Consulting Appoints Kimberly Bennett as Chief Operating Officer

Sequoia Biotech

Sequoia Biotech Consulting (Sequoia), a leading life sciences consulting firm renowned for its expertise in scaling life science organizations to deliver high-quality therapeutics, diagnostics, and medical devices, proudly announces the appointment of Kimberly Bennett as Chief Operating Officer (COO).

Having served as an invaluable member of Sequoia’s executive leadership team for over 8 years, Kimberly Bennett has demonstrated exemplary leadership and innovation in her previous role as Senior Vice President of the Strategy and Programs division at Sequoia. With over 30 years of experience fostering business excellence and cultivating high-performing cultures within the life sciences sector, Ms. Bennett embodies the ideal candidate for this pivotal role. In her new position, Ms. Bennett will be instrumental in driving and supporting Sequoia’s growth trajectory, ensuring scalability and consistency across the organization’s internal operations, and delivery of tailored solutions to our clients.

Also Read: Firefly Bio Debuts With $94 Million Series A Financing

Brandy Bullen, Founder and chief executive officer of Sequoia, shared about Ms. Bennett’s appointment, stating, “I am thrilled to have Kim step into this new role to further support Sequoia in our continued growth and build on the amazing foundation we’ve established over the last 10 years. Her depth of experience, strategic mindset, and unwavering commitment to excellence will undoubtedly bring us closer to realizing our ambitious goals and aspirations in the coming years and strengthen our mission to supporting our life science partners in advancing human health.”

Reflecting on her new role, Kimberly Bennett stated, “I am honored to assume the position of Chief Operating Officer at Sequoia and continue working with our remarkable and talented team. Together, we remain committed to delivering best in class services to our life science partners and offering innovative solutions to meet their critical needs, ultimately benefiting patients in need.”

SOURCE: PRWeb

Exit mobile version